Australia - inglese - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: sodium hydroxide; mannitol; magnesium stearate; sodium stearylfumarate; povidone; meglumine - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Australia - inglese - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: mannitol; meglumine; sodium hydroxide; povidone; sodium stearylfumarate; magnesium stearate - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Canada - inglese - Health Canada

apotex inc - telmisartan; amlodipine (amlodipine besylate) - tablet - 40mg; 5mg - telmisartan 40mg; amlodipine (amlodipine besylate) 5mg - angiotensin ii receptor antagonists

Canada - inglese - Health Canada

apotex inc - telmisartan; amlodipine (amlodipine besylate) - tablet - 40mg; 10mg - telmisartan 40mg; amlodipine (amlodipine besylate) 10mg - angiotensin ii receptor antagonists

Canada - inglese - Health Canada

apotex inc - telmisartan; amlodipine (amlodipine besylate) - tablet - 80mg; 5mg - telmisartan 80mg; amlodipine (amlodipine besylate) 5mg - angiotensin ii receptor antagonists

Canada - inglese - Health Canada

apotex inc - telmisartan; amlodipine (amlodipine besylate) - tablet - 80mg; 10mg - telmisartan 80mg; amlodipine (amlodipine besylate) 10mg - angiotensin ii receptor antagonists

Stati Uniti - inglese - NLM (National Library of Medicine)

boehringer ingelheim pharmaceuticals, inc. - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - telmisartan 40 mg - twynsta (telmisartan/amlodipine) tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including angiotensin ii receptor blockers and dihydropyridine calcium channel blockers. there are no controlled trials demonstrating risk reduction with twynsta. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education

Australia - inglese - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - telmisartan -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; croscarmellose sodium; brilliant blue fcf aluminium lake; mannitol; magnesium stearate; microcrystalline cellulose; povidone; silicon dioxide; iron oxide yellow; sodium hydroxide; meglumine; iron oxide black; isomalt - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: mannitol; iron oxide black; brilliant blue fcf aluminium lake; calcium hydrogen phosphate; sodium hydroxide; iron oxide yellow; meglumine; isomalt; croscarmellose sodium; magnesium stearate; povidone; microcrystalline cellulose; silicon dioxide - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.